Logo image of XX.CA

AVANTE CORP (XX.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:XX - CA05352F1099 - Common Stock

1.12 CAD
-0.04 (-3.45%)
Last: 12/5/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XX. XX was compared to 2 industry peers in the Diversified Consumer Services industry. While XX seems to be doing ok healthwise, there are quite some concerns on its profitability. XX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

XX had negative earnings in the past year.
XX had a positive operating cash flow in the past year.
In the past 5 years XX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: XX reported negative operating cash flow in multiple years.
XX.CA Yearly Net Income VS EBIT VS OCF VS FCFXX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M

1.2 Ratios

The Return On Assets of XX (-3.88%) is better than 66.67% of its industry peers.
With a decent Return On Equity value of -7.06%, XX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Invested Capital value of 0.90%, XX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -3.88%
ROE -7.06%
ROIC 0.9%
ROA(3y)-6.04%
ROA(5y)-6.99%
ROE(3y)-10.77%
ROE(5y)-16.93%
ROIC(3y)N/A
ROIC(5y)N/A
XX.CA Yearly ROA, ROE, ROICXX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

XX has a Operating Margin of 0.55%. This is in the better half of the industry: XX outperforms 66.67% of its industry peers.
XX has a worse Gross Margin (39.02%) than 66.67% of its industry peers.
XX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.55%
PM (TTM) N/A
GM 39.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y10.86%
XX.CA Yearly Profit, Operating, Gross MarginsXX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XX is destroying value.
XX has about the same amout of shares outstanding than it did 1 year ago.
XX has more shares outstanding than it did 5 years ago.
XX has a worse debt/assets ratio than last year.
XX.CA Yearly Shares OutstandingXX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
XX.CA Yearly Total Debt VS Total AssetsXX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

XX has an Altman-Z score of 2.40. This is not the best score and indicates that XX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.40, XX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
XX has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
The Debt to FCF ratio of XX (0.85) is better than 66.67% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that XX is not too dependend on debt financing.
XX has a better Debt to Equity ratio (0.05) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.85
Altman-Z 2.4
ROIC/WACC0.12
WACC7.58%
XX.CA Yearly LT Debt VS Equity VS FCFXX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.81 indicates that XX should not have too much problems paying its short term obligations.
XX's Current ratio of 1.81 is amongst the best of the industry. XX outperforms 100.00% of its industry peers.
XX has a Quick Ratio of 1.65. This is a normal value and indicates that XX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of XX (1.65) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.65
XX.CA Yearly Current Assets VS Current LiabilitesXX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1

3. Growth

3.1 Past

XX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.09%, which is quite impressive.
Looking at the last year, XX shows a quite strong growth in Revenue. The Revenue has grown by 17.15% in the last year.
Measured over the past years, XX shows a decrease in Revenue. The Revenue has been decreasing by -7.50% on average per year.
EPS 1Y (TTM)76.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.36%
Revenue 1Y (TTM)17.15%
Revenue growth 3Y22.97%
Revenue growth 5Y-7.5%
Sales Q2Q%9.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XX.CA Yearly Revenue VS EstimatesXX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
XX.CA Yearly EPS VS EstimatesXX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 0 0.05 -0.05 0.1 -0.1 -0.15

2

4. Valuation

4.1 Price/Earnings Ratio

XX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XX.CA Price Earnings VS Forward Price EarningsXX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XX indicates a rather cheap valuation: XX is cheaper than 100.00% of the companies listed in the same industry.
XX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. XX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.43
EV/EBITDA 14.44
XX.CA Per share dataXX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for XX!.
Industry RankSector Rank
Dividend Yield N/A

AVANTE CORP

TSX-V:XX (12/5/2025, 7:00:00 PM)

1.12

-0.04 (-3.45%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-24 2025-11-24
Earnings (Next)02-24 2026-02-24
Inst Owners0.12%
Inst Owner ChangeN/A
Ins Owners24.94%
Ins Owner ChangeN/A
Market Cap29.85M
Revenue(TTM)35.38M
Net Income(TTM)-893.50K
Analysts82.86
Price Target2.3 (105.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF 19.43
P/OCF 11.5
P/B 2.36
P/tB 4.83
EV/EBITDA 14.44
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY5.15%
OCF(TTM)0.1
OCFY8.7%
SpS1.33
BVpS0.47
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.88%
ROE -7.06%
ROCE 1.26%
ROIC 0.9%
ROICexc 1.24%
ROICexgc 2.93%
OM 0.55%
PM (TTM) N/A
GM 39.02%
FCFM 4.34%
ROA(3y)-6.04%
ROA(5y)-6.99%
ROE(3y)-10.77%
ROE(5y)-16.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y10.86%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.85
Debt/EBITDA 0.37
Cap/Depr 63.87%
Cap/Sales 3%
Interest Coverage 250
Cash Conversion 140.08%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.65
Altman-Z 2.4
F-Score6
WACC7.58%
ROIC/WACC0.12
Cap/Depr(3y)43.23%
Cap/Depr(5y)32.2%
Cap/Sales(3y)2.35%
Cap/Sales(5y)1.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.15%
Revenue growth 3Y22.97%
Revenue growth 5Y-7.5%
Sales Q2Q%9.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y107.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.67%
OCF growth 3Y-43.11%
OCF growth 5YN/A

AVANTE CORP / XX.CA FAQ

What is the ChartMill fundamental rating of AVANTE CORP (XX.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to XX.CA.


What is the valuation status for XX stock?

ChartMill assigns a valuation rating of 1 / 10 to AVANTE CORP (XX.CA). This can be considered as Overvalued.


Can you provide the profitability details for AVANTE CORP?

AVANTE CORP (XX.CA) has a profitability rating of 2 / 10.